$VRTX
VERTEX PHARMACEUTICALS INC / MA

2013 Q3 Form 10-Q Financial Statement

#000087532013000045 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q3
Revenue $221.7M $336.0M
YoY Change -34.02% -49.03%
Cost Of Revenue $20.05M $30.68M
YoY Change -34.65% -13.05%
Gross Profit $201.7M $305.3M
YoY Change -33.96% -51.06%
Gross Profit Margin 90.96% 90.87%
Selling, General & Admin $86.43M $97.68M
YoY Change -11.52% -11.72%
% of Gross Profit 42.86% 31.99%
Research & Development $219.4M $200.2M
YoY Change 9.63% 5.88%
% of Gross Profit 108.82% 65.56%
Depreciation & Amortization $9.500M $8.600M
YoY Change 10.47% 11.69%
% of Gross Profit 4.71% 2.82%
Operating Expenses $305.9M $297.8M
YoY Change 2.69% -0.62%
Operating Profit -$123.6M -$1.071M
YoY Change 11436.51% -100.5%
Interest Expense -$104.0K -$13.00K
YoY Change 700.0% -100.18%
% of Operating Profit
Other Income/Expense, Net $4.760M -$4.041M
YoY Change -217.79%
Pretax Income -$118.9M -$5.112M
YoY Change 2225.9% -102.55%
Income Tax $2.555M $21.36M
% Of Pretax Income
Net Earnings -$124.1M -$57.54M
YoY Change 115.72% -126.02%
Net Earnings / Revenue -55.99% -17.13%
Basic Earnings Per Share -$0.54 -$0.27
Diluted Earnings Per Share -$0.54 -$0.27
COMMON SHARES
Basic Shares Outstanding 230.5M shares 213.8M shares
Diluted Shares Outstanding 230.5M shares 213.8M shares

Balance Sheet

Concept 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.423B $1.299B
YoY Change 9.55% 97.12%
Cash & Equivalents $583.2M $436.9M
Short-Term Investments $839.0M $862.0M
Other Short-Term Assets $92.00M $110.0M
YoY Change -16.36% 48.65%
Inventory $13.54M $86.28M
Prepaid Expenses
Receivables $120.3M $139.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.649B $1.635B
YoY Change 0.86% 31.18%
LONG-TERM ASSETS
Property, Plant & Equipment $648.9M $124.1M
YoY Change 422.7% 22.59%
Goodwill $31.00M $30.99M
YoY Change 0.03% -7.49%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.474M $10.39M
YoY Change -66.57% -24.61%
Total Long-Term Assets $934.1M $1.084B
YoY Change -13.85% 28.17%
TOTAL ASSETS
Total Short-Term Assets $1.649B $1.635B
Total Long-Term Assets $934.1M $1.084B
Total Assets $2.583B $2.719B
YoY Change -5.0% 29.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.53M $83.73M
YoY Change -38.45% 70.02%
Accrued Expenses $280.8M $273.3M
YoY Change 2.77% 18.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.00M
YoY Change
Total Short-Term Liabilities $409.5M $406.7M
YoY Change 0.68% -25.91%
LONG-TERM LIABILITIES
Long-Term Debt $432.0M $400.0M
YoY Change 8.0% 0.0%
Other Long-Term Liabilities $10.78M $28.74M
YoY Change -62.48% 266.2%
Total Long-Term Liabilities $10.78M $28.74M
YoY Change -62.48% 266.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $409.5M $406.7M
Total Long-Term Liabilities $10.78M $28.74M
Total Liabilities $1.096B $1.454B
YoY Change -24.62% -3.83%
SHAREHOLDERS EQUITY
Retained Earnings -$4.011B -$3.446B
YoY Change 16.41%
Common Stock $5.277B $4.474B
YoY Change 17.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.265B $1.028B
YoY Change
Total Liabilities & Shareholders Equity $2.583B $2.719B
YoY Change -5.0% 29.96%

Cashflow Statement

Concept 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$124.1M -$57.54M
YoY Change 115.72% -126.02%
Depreciation, Depletion And Amortization $9.500M $8.600M
YoY Change 10.47% 11.69%
Cash From Operating Activities -$13.70M $106.0M
YoY Change -112.92% 147.09%
INVESTING ACTIVITIES
Capital Expenditures -$18.50M -$21.40M
YoY Change -13.55% 114.0%
Acquisitions
YoY Change
Other Investing Activities $68.10M -$109.9M
YoY Change -161.97% -448.89%
Cash From Investing Activities $49.50M -$131.3M
YoY Change -137.7% -710.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.00M 8.200M
YoY Change 58.54% -59.0%
NET CHANGE
Cash From Operating Activities -13.70M 106.0M
Cash From Investing Activities 49.50M -131.3M
Cash From Financing Activities 13.00M 8.200M
Net Change In Cash 48.80M -17.10M
YoY Change -385.38% -120.26%
FREE CASH FLOW
Cash From Operating Activities -$13.70M $106.0M
Capital Expenditures -$18.50M -$21.40M
Free Cash Flow $4.800M $127.4M
YoY Change -96.23% 140.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
101292000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
51533000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120281000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143250000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264884000 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
280848000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-550000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-550000 USD
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5274307000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4519448000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1097000 USD
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 USD
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
6700000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87537000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
104818000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4230000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6650000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2012Q4 us-gaap Assets
Assets
2759288000 USD
CY2013Q3 us-gaap Assets
Assets
2582748000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1589585000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
1648631000 USD
CY2013Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
839469000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
831808000 USD
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
13707000 USD
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
14429000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
27552000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
38520000 USD
CY2013Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
39381000 USD
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15170000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
61259000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
1883000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
8481000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
8924000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
15608000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
18077000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
409000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
-7449000 USD
CY2013Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
53810000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
583181000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489407000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475320000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436886000 USD
CY2013Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
48700000 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
217286868 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
233592201 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
233592201 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
217286868 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2149000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
2311000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57286000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30247000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-489313000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-123452000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4530000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
31076000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-13688000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
57825000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
27578000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-503001000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-127982000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-26210000 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
290700000 USD
CY2013Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
467600000 USD
CY2012Q4 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
400000000 USD
CY2013Q3 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
75698000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
161147000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20048000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
30680000 USD
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
337077000 USD
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
355765000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1113240000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1490104000 USD
CY2012Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1100000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
399842000 USD
CY2013Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.03
CY2013Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.07
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
127600000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
27566000 USD
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31007000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
96242000 USD
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
77354000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2600000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1500000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
60300000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
150203000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
280367000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25818000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30734000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
32315000 USD
CY2012Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
7856000 USD
CY2013Q3 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
7291000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
31023000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-110000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
2591000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
888000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
885000 USD
CY2012Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
339000 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
204000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1097000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-1097000 USD
us-gaap Extraordinary Item Earnings Per Share Impact Net
ExtraordinaryItemEarningsPerShareImpactNet
1280
CY2013Q3 us-gaap Goodwill
Goodwill
30992000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
30992000 USD
CY2013Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2012Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2012Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2013Q3 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
412900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
68391000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-129413000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-635864000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5112000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-751000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-132863000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41450000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21355000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1359000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
46005000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-43538000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20737000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
12027000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
32872000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-32203000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-15447000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5212000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-32419000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-130164000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
35759000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1094000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
997000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16477000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22698000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-31807000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1923000 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-18924000 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
23075000 USD
us-gaap Interest Paid
InterestPaid
6700000 USD
us-gaap Interest Paid
InterestPaid
6700000 USD
CY2013Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5325000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15393000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
30464000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
13537000 USD
CY2013Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
232000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3754000 USD
CY2013Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7980000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11317000 USD
us-gaap Inventory Write Down
InventoryWriteDown
10358000 USD
us-gaap Inventory Write Down
InventoryWriteDown
78000000 USD
CY2013Q3 us-gaap Inventory Write Down
InventoryWriteDown
5300000 USD
CY2012Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
164359000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
167367000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
1096068000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1524906000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2759288000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2582748000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
409499000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
432624000 USD
CY2013Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
31900000 USD
CY2013Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2012Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
196672000 USD
CY2013Q3 us-gaap Minority Interest
MinorityInterest
182168000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1094000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1263000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-38434000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
93774000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-432973000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
7249000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80425000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
227282000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-124132000 USD
us-gaap Net Income Loss
NetIncomeLoss
-489313000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-57543000 USD
us-gaap Net Income Loss
NetIncomeLoss
-30884000 USD
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
31076000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4530000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-13688000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
57825000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
8070000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
167996000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
176484000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
5856000 USD
CY2013Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1071000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
79808000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-134065000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-629286000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3474000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9668000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
514000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
313000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
188000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
257000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
680000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
637000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
324000 USD
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
166000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
69000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000 USD
CY2013Q3 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
250600000 USD
CY2012Q4 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
663500000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20417000 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21824000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13902000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10782000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1393000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
304000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6578000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11417000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4041000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4652000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1309044000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1850015000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36922000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43094000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24673000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41104000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
242360000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
174950000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-63242000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6272000 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
31800000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1842361000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
941314000 USD
us-gaap Profit Loss
ProfitLoss
26941000 USD
us-gaap Profit Loss
ProfitLoss
-503001000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
-26467000 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-128662000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
648924000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
433609000 USD
CY2013Q3 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
39624000 USD
CY2012Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
38530000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
158000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2408000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
14601000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200161000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
228624000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
669174000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
593076000 USD
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
51059000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
69983000 USD
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
127000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
31934000 USD
CY2013Q3 us-gaap Restructuring Charges
RestructuringCharges
12048000 USD
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
696000 USD
us-gaap Restructuring Charges
RestructuringCharges
12863000 USD
us-gaap Restructuring Charges
RestructuringCharges
1650000 USD
CY2013Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
9858000 USD
CY2012Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4758000 USD
CY2013Q3 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
16280000 USD
CY2012Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
18570000 USD
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-2158000 USD
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
2810000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4011180000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3521867000 USD
CY2012Q3 us-gaap Revenues
Revenues
336006000 USD
us-gaap Revenues
Revenues
1193048000 USD
CY2013Q3 us-gaap Revenues
Revenues
221700000 USD
us-gaap Revenues
Revenues
860818000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
98047000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
119705000 USD
CY2012Q3 us-gaap Royalty Revenue
RoyaltyRevenue
25586000 USD
CY2013Q3 us-gaap Royalty Revenue
RoyaltyRevenue
27012000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1052149000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
303501000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
708823000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
186653000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
87754000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
326344000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97684000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
287154000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
86649000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
103933000 USD
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
27582000 USD
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
31308000 USD
CY2013Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
7344000 shares
CY2013Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
16807000 shares
CY2013Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
37.87
CY2013Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
44.47
CY2013Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y1M2D
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
402265000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
248216000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
183022000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
999180000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
1264888000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1195852000 USD
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1447056000 USD
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1226447000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
928476000 USD
CY2012Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
98000000 USD
CY2013Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, noncontrolling interest (Alios) and the income tax provision. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's significant accounting policies are described in Note&#160;A, "Nature of Business and Accounting Policies," in the 2012 Annual Report on Form&#160;10-K.</font></div></div>
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
15678000 USD
CY2013Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
88487000 USD
CY2012Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
75393000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222764000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211053000 shares
CY2012Q4 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1321215000 USD
CY2013Q3 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1422650000 USD
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213767000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
230505000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211053000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222764000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230505000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
213767000 shares
vrtx Amounts Reclassified From Accumulated Other Comprehensive Income Loss
AmountsReclassifiedFromAccumulatedOtherComprehensiveIncomeLoss
0 USD
CY2013Q3 vrtx Capital Leases Future Minimumpaymentsduein Sixyears
CapitalLeasesFutureMinimumpaymentsdueinSixyears
7877000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1321019000 USD
CY2013Q3 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1422447000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
217000 USD
CY2013Q3 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
252000 USD
CY2013Q3 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
49000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
21000 USD
CY2012Q3 vrtx Collaborative Revenues
CollaborativeRevenues
6919000 USD
CY2013Q3 vrtx Collaborative Revenues
CollaborativeRevenues
8035000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
32290000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
42852000 USD
CY2012Q4 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
268031000 USD
CY2013Q3 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
392569000 USD
CY2013Q3 vrtx Deferred Revenue Royalty Purchase Agreement
DeferredRevenueRoyaltyPurchaseAgreement
71500000 USD
CY2011Q2 vrtx Initial Term Of Lease Agreement
InitialTermOfLeaseAgreement
P15Y
CY2011Q2 vrtx Lease Agreement Number Of Leases
LeaseAgreementNumberOfLeases
2 leases
CY2011Q2 vrtx Lease Agreements Number Of Buildings
LeaseAgreementsNumberOfBuildings
2 building
CY2011Q2 vrtx Optional Term Of Lease Agreement
OptionalTermOfLeaseAgreement
P10Y
vrtx Other Comprehensive Income Loss Before Reclassifications
OtherComprehensiveIncomeLossBeforeReclassifications
0 USD
CY2008 vrtx Proceeds From Sale Of Royalty Rights
ProceedsFromSaleOfRoyaltyRights
160000000 USD
CY2013Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2011Q2 vrtx Square Footage Of Leased Property
SquareFootageOfLeasedProperty
1100000 squarefeet
vrtx Valuation Allowances And Reserves Provision
ValuationAllowancesAndReservesProvision
-193701000 USD
vrtx Valuation Allowances And Reserves Sales Credits Or Payments Current
ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent
-196285000 USD
CY2013Q3 dei Amendment Flag
AmendmentFlag
false
CY2013Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q3 dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
CY2013Q3 dei Document Type
DocumentType
10-Q
CY2013Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000875320
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
233756871 shares
CY2013Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q3 dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA

Files In Submission

Name View Source Status
0000875320-13-000045-index-headers.html Edgar Link pending
0000875320-13-000045-index.html Edgar Link pending
0000875320-13-000045.txt Edgar Link pending
0000875320-13-000045-xbrl.zip Edgar Link pending
a2013q210-q_exhibit3112.htm Edgar Link pending
a2013q210-q_exhibit3122.htm Edgar Link pending
a2013q210-q_exhibit3212.htm Edgar Link pending
a2013q310-q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20130930.xml Edgar Link completed
vrtx-20130930.xsd Edgar Link pending
vrtx-20130930_cal.xml Edgar Link unprocessable
vrtx-20130930_def.xml Edgar Link unprocessable
vrtx-20130930_lab.xml Edgar Link unprocessable
vrtx-20130930_pre.xml Edgar Link unprocessable